Myracle Therapeutics Inc.

East Hanover, NJ Myracle Therapeutics

UEI
GRDUWPPDLQ41
CAGE
9N3X6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
40 Tiffany Dr, East Hanover, NJ 07936, USA
Website
myracletx.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Myracle Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Discovery and optimization of novel, selective HDAC11 inhibitors for the treatment of obesity and related diseases. -… Grant · R44DK139886 National Institute of Diabetes and Digestive and Kidney Diseases $628,927

Quick answers

What is Myracle Therapeutics Inc.'s UEI?

Myracle Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is GRDUWPPDLQ41.

What is Myracle Therapeutics Inc.'s CAGE code?

Myracle Therapeutics Inc.'s CAGE code is 9N3X6.

What is Myracle Therapeutics Inc.'s primary NAICS code?

Myracle Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Myracle Therapeutics Inc. located?

Myracle Therapeutics Inc.'s physical address in SAM.gov is 40 Tiffany Dr, East Hanover, NJ 07936, USA.

Is Myracle Therapeutics Inc. registered in SAM.gov?

Yes. Myracle Therapeutics Inc.'s SAM.gov registration is active through March 22, 2027.

What is Myracle Therapeutics Inc.'s most recent federal award?

Myracle Therapeutics Inc.'s most recent federal grant award is Discovery and optimization of novel, selective HDAC11 inhibitors for the treatment of obesity and related diseases. -… (R44DK139886), from National Institute of Diabetes and Digestive and Kidney Diseases, on July 25, 2024.

On GovTribe

See Myracle Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors